medical-device-investing Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
medical-device-investing AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
medical-device-investing AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
medical-device-investing AVITA Medical to Present at the Piper Sandler 37?? Annual Healthcare Conference
medical-device-investing Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
medical-device-investing CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds
medical-device-investing AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
medical-device-investing Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical's RECELL® System
BlackRock® Canada Announces Final January Cash Distributions for the iShares® Premium Money Market ETF
